Celgene Corp
Change company Symbol lookup
Select an option...
CELG Celgene Corp
PII Polaris Industries Inc
DRI Darden Restaurants Inc
ABM ABM Industries Inc
FRAN Francesca's Holdings Corp
ED Consolidated Edison Inc
VGZ Vista Gold Corp
GRU.SO Svensk Exportkredit AB
AVD American Vanguard Corp
BAC Bank of America Corp
Go

Health Care : Biotechnology | Large Cap GrowthCompany profile

Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Its commercial-stage products include REVLIMID (lenalidomide), POMALYST/IMNOVID (pomalidomide), OTEZLA (apremilast), ABRAXANE (paclitaxel albumin-bound particles for injectable suspension), VIDAZA, azacitidine for injection (generic version of VIDAZA) and THALOMID (thalidomide). Its clinical trial activity includes trials across the disease areas of hematology, solid tumors, and inflammation and immunology. The Company also markets ISTODAX, which is an epigenetic modifier. The Company is also evaluating AG-221 (enasidenib) in combination with VIDAZA in newly diagnosed acute myeloid leukemia with isocitrate dehydrogenase-2 mutations.

Premarket

Last Trade
Delayed
$67.00
0.37 (0.56%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$66.63
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
8,767

10-day average volume:
6,878,733
8,767
  • Prev Close
    66.63
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    6.9M
  • Last (time)
    4:00p ET 12/18/18
  • Last (size)
    100
  • 52-Wk Range
    65.76 - 110.20
    LowHigh
  • (12/18/17 - 12/18/18)
    1.32%
  • 29.2%
  • Market Cap
    46.6B
  • Shares Outstanding
    699.3M
  • 5.57
  • 11.97x
  • No dividend
  • Ex-dividend
    No dividend
  • 1.4
  • 73.31
  • (% of float 11/30/18)
    2.09

Latest News

December 19, 2018
7:00 am ET
PR Newswire
December 18, 2018
8:35 am ET
BusinessWire
8:30 am ET
BusinessWire
December 17, 2018
7:30 am ET
BusinessWire
December 13, 2018
9:16 am ET
PR Newswire
December 10, 2018
7:20 am ET
Globe Newswire
December 05, 2018
4:30 pm ET
BusinessWire
December 04, 2018
5:20 am ET
BusinessWire
7:30 pm ET
BusinessWire
December 03, 2018
8:30 am ET
BusinessWire
7:35 pm ET
BusinessWire
7:30 pm ET
BusinessWire
December 02, 2018
5:00 pm ET
BusinessWire
10:35 am ET
BusinessWire
December 01, 2018
5:00 pm ET
BusinessWire
November 28, 2018
8:30 am ET
PR Newswire
8:00 am ET
PR Newswire
November 27, 2018
7:30 am ET
BusinessWire
November 14, 2018
3:09 pm ET
MarketWatch
8:00 am ET
PR Newswire
7:58 am ET
PR Newswire
November 10, 2018
9:54 am ET
MarketWatch
November 06, 2018
8:35 am ET
MarketWatch
November 05, 2018
1:00 pm ET
Globe Newswire
November 02, 2018
7:30 am ET
BusinessWire
November 01, 2018
9:50 am ET
BusinessWire
October 31, 2018
8:00 am ET
Globe Newswire
October 28, 2018
7:32 am ET
MarketWatch
October 25, 2018
7:45 am ET
MarketWatch
7:37 am ET
MarketWatch
7:36 am ET
MarketWatch
7:35 am ET
MarketWatch
7:34 am ET
MarketWatch
7:34 am ET
MarketWatch
7:30 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.